FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
811 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | Cipla USA Inc. | Aug 30, 2026 | 69097-038 |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | Cipla USA Inc. | Aug 30, 2026 | 69097-039 |
| Propranolol Hydrochloride | Propranolol hydrochloride 60 mg/1 | Capsule, Extended releaseOral | Creekwood Pharmaceuticals LLC | Aug 29, 2026 | 82619-132 |
| Propranolol Hydrochloride | Propranolol hydrochloride 80 mg/1 | Capsule, Extended releaseOral | Creekwood Pharmaceuticals LLC | Aug 29, 2026 | 82619-133 |
| Propranolol Hydrochloride | Propranolol hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Creekwood Pharmaceuticals LLC | Aug 29, 2026 | 82619-134 |
| Propranolol Hydrochloride | Propranolol hydrochloride 160 mg/1 | Capsule, Extended releaseOral | Creekwood Pharmaceuticals LLC | Aug 29, 2026 | 82619-135 |
| Qlonilikclonidine hydrochloride | Clonidine hydrochloride .05 mg/mL | SolutionOral | CMP Pharma, Inc. | Aug 28, 2026 | 46287-085 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | Aug 28, 2026 | 63020-715 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | Aug 28, 2026 | 63020-725 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | Aug 28, 2026 | 63020-735 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | Aug 28, 2026 | 63020-745 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | Aug 28, 2026 | 63020-765 |
| Hydrocortisone Acetate | Hydrocortisone acetate 25 mg/1 | SuppositoryRectal | Preferred Pharmaceuticals, Inc. | Aug 28, 2026 | 68788-4190 |
| Tolvaptan | — | Kit | Teva Pharmaceuticals, Inc. | Aug 27, 2026 | 0480-3311 |
| Tolvaptan | — | Kit | Teva Pharmaceuticals, Inc. | Aug 27, 2026 | 0480-3312 |
| Tolvaptan | — | Kit | Teva Pharmaceuticals, Inc. | Aug 27, 2026 | 0480-3313 |
| Tolvaptan | — | Kit | Teva Pharmaceuticals, Inc. | Aug 27, 2026 | 0480-3314 |
| Tolvaptan | — | Kit | Teva Pharmaceuticals, Inc. | Aug 27, 2026 | 0480-3414 |
| Fidaxomicin | Fidaxomicin 200 mg/1 | Tablet, Film coatedOral | Sandoz Inc | Aug 27, 2026 | 0781-5194 |
| Trospium Chloride | Trospium chloride 20 mg/1 | Tablet, Film coatedOral | MAJOR PHARMACEUTICALS | Aug 27, 2026 | 0904-7619 |
| Voriconazole | Voriconazole 50 mg/1 | Tablet, Film coatedOral | American Health Packaging | Aug 27, 2026 | 60687-968 |
| Voriconazole | Voriconazole 200 mg/1 | Tablet, Film coatedOral | American Health Packaging | Aug 27, 2026 | 60687-979 |
| Bixlenvobictegravir/lenacapavir | Bictegravir sodium 75 mg/1; Lenacapavir sodium 50 mg/1 | Tablet, Film coatedOral | Gilead Sciences, Inc. | Aug 27, 2026 | 61958-3601 |
| Metformin Hydrochloride | Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc. | Aug 27, 2026 | 68788-4185 |
| Pioglitazone | Pioglitazone hydrochloride 30 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | Aug 27, 2026 | 68788-4187 |